Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

about

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

Item

http://www.wikidata.org/entity/Q47197460

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@en

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@nl

type

Item

label

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@en

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@nl

prefLabel

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@en

Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

@nl

P1476

Advanced glycation end products as a source of artifacts in immunoenzymatic methods

@en

P2093

A Bronowicka-Szydełko

http://www.w3.org/2001/XMLSchema#string

A Chwiłkowska

http://www.w3.org/2001/XMLSchema#string

A Gamian

http://www.w3.org/2001/XMLSchema#string

K Maksymowicz

http://www.w3.org/2001/XMLSchema#string

K Stach

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products and diabetic complications

Detection of altered extracellular matrix in surface layers of unstable carotid plaque: an optical spectroscopy, birefringence and microarray genetic analysis.

Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits.

Species differences of elastic and collagenous tissue--influence of maturation and age.

Collagen synthesis in atherosclerosis: too much and not enough.

The growth and development of the rat aorta. II. Changes in nucleic acid and scleroprotein content.

Advanced glycation end products and diabetic cardiovascular disease.

Vascular wall extracellular matrix proteins and vascular diseases

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

P2888

s10719-017-9805-4

P304

95-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10719-017-9805-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Celina Pezowicz

Aleksandra Kuzan

P577

2018-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29305778

http://www.w3.org/2001/XMLSchema#string

P932

5849676

http://www.w3.org/2001/XMLSchema#string